Skip to main content

UBS Group AG

Position in ORMP — Oramed Pharmaceuticals Inc.

CIK 1610520 ZURICH, V8

Position in ORMP

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$325,496
+$285,829 QoQ
Shares Held
67,671
+480.0% QoQ
Ownership
0.163%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 84 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in ORMP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,747,178,871 across 561 Biotechnology names. ORMP ranks #314 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ORMP

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $325,496 67,671
2026-03-31 $39,667 11,667
2025-12-31 $7,337 2,575
2025-09-30 $941 357
2025-06-30 $28,752 12,779
2025-03-31 $76,146 35,583
2024-12-31 $273,413 112,981
2024-09-30 $68,768 28,184
2024-06-30 $23,877 9,291
2024-03-31 $13,574 4,649
2023-12-31 $11,702 5,066
2023-09-30 $16,197 6,206
2023-06-30 $21,988 6,142
2023-03-31 $216,111 99,134
2022-12-31 $128,865 10,712
2022-09-30 $54,528 8,415
2022-06-30 $20,843 4,551
2022-03-31 $26,218 3,031
2021-12-31 $195,292 13,676
2021-09-30 $25,804 1,174
2021-06-30 $356,991 26,681
2021-03-31 $18,114 1,783
2020-12-31 $559 132
2020-09-30 $24,426 9,359
2020-06-30 $14,225 4,030
2020-03-31 $23,173 7,623